Kisqali

Novartis pauses enrollment in some Kisqali trials to fix manufacturing
BioPharma Dive
Wed, 04/10/24 - 05:28 pm
Novartis
Kisqali
drug manufacturing
breast cancer
clinical trials
Novartis gears up for label expansion for Kisqali with Phase III results
Clinical Trials Arena
Mon, 12/11/23 - 11:18 am
Novartis
Kisqali
FDA
clinical trials
early breast cancer
breast cancer
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
Novartis drug helps stop breast cancer’s return in large study
BioPharma Dive
Fri, 06/2/23 - 11:24 am
Novartis
Kisqali
clinical trials
breast cancer
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
ASCO 2023
Merck
Keytruda
Novartis
Kisqali
non-small cell lung cancer
early breast cancer
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
BioSpace
Mon, 03/27/23 - 11:27 am
Novartis
clinical trials
Kisqali
breast cancer
Novartis’ Kisqali Hits Mark in Mid-Stage Breast Cancer Trial
BioSpace
Wed, 12/7/22 - 11:39 pm
Novartis
Kisqali
breast cancer
clinical trials
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Drugs.com
Sun, 09/19/21 - 11:58 pm
ESMO
Novartis
clinical trials
Kisqali
breast cancer
#ASCO21: Novartis keeps building out survival data for Kisqali, hoping to keep the pressure on Pfizer's Ibrance
Endpoints
Thu, 06/3/21 - 12:09 am
ASCO 2021
Novartis
Kisqali
breast cancer
SABCS: Novartis touts Kisqali's 5-year breast cancer survival, advantage over Pfizer's Ibrance
Fierce Pharma
Wed, 12/9/20 - 10:51 am
Novartis
Kisqali
breast cancer
SABCS
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
RAPS.org
Sun, 09/15/19 - 09:47 pm
breast cancer
FDA
Ibrance
Kisqali
Verzenio
Pfizer
Novartis
Eli Lilly
Novartis' Kisqali sharpens survival edge with second ph3 win
Fierce Pharma
Thu, 08/1/19 - 12:00 am
Novartis
Kisqali
breast cancer
clinical trials
ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
Fierce Pharma
Sat, 06/1/19 - 12:45 pm
breast cancer
ASCO 2019
Novartis
clinical trials
Kisqali
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Sat, 10/20/18 - 10:37 pm
Lilly
Verzenio
breast cancer
Pfizer
Ibrance
Novartis
Kisqali
NICE
FDA Approves First Cancer Drug Under New Real Time Review Program
CP Wire
Wed, 07/18/18 - 01:39 pm
FDA
Novartis
Kisqali
breast cancer
Scott Gottlieb
Real Time Oncology Review
FDA Approves First Cancer Drug Under New Real Time Review Program
Wed, 07/18/18 - 01:38 pm
FDA
Scott Gottlieb
Kisqali
breast cancer
ASCO: Novartis makes a case for earlier Kisqali use. Will 'conservative' docs run with it?
Fierce Pharma
Mon, 06/4/18 - 09:31 am
Novartis
Kisqali
metastatic breast cancer
ASCO 2018
HR-positive
HER2-negative breast cancer
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
cancer
Merck
Japan
Keytruda
Seattle Genetics
Adcetris
Novartis
Kisqali
Novartis Gets Second Breakthrough Designation for Kisqali
Yahoo/Zacks.com
Thu, 01/4/18 - 09:50 pm
Novartis
Kisqali
breast cancer
In Young Women, Kisqali Slows Metastatic Breast Cancer And Relieves Symptoms
Forbes
Thu, 12/7/17 - 09:10 am
Novartis
Kisqali
metastatic breast cancer

Pages